BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Warner Bros
WBD
|
+$2.81B |
| 2 |
Linde
LIN
|
+$2.35B |
| 3 |
Chevron
CVX
|
+$1.53B |
| 4 |
Pfizer
PFE
|
+$1.38B |
| 5 |
UnitedHealth
UNH
|
+$1.35B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$3.75B |
| 2 |
CERN
Cerner Corp
CERN
|
+$2.23B |
| 3 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$1.1B |
| 4 |
Baidu
BIDU
|
+$1.07B |
| 5 |
NXP Semiconductors
NXPI
|
+$998M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.27% |
| 2 | Healthcare | 15.23% |
| 3 | Financials | 12.33% |
| 4 | Consumer Discretionary | 9.59% |
| 5 | Industrials | 8.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NUVA
1201
DELISTED
NuVasive, Inc.
NUVA
| $310M | 0.01% |
6,309,952
+348,127
| +6% | +$18.7M |
|
1202
Novanta
NOVT
$6.29B
| $310M | 0.01% |
2,557,873
+120,040
| +5% | +$15.1M |
|
1203
Ironwood Pharmaceuticals
IRWD
$714M
| $310M | 0.01% |
26,890,220
+12,353,461
| +85% | +$146M |
|
1204
Installed Building Products
IBP
$6.49B
| $310M | 0.01% |
3,727,490
-63,577
| -2% | -$5.44M |
|
|
NARI
1205
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $310M | 0.01% |
4,557,530
+2,236,840
| +96% | +$161M |
|
1206
Urban Edge Properties
UE
$2.73B
| $309M | 0.01% |
20,320,047
-130,432
| -0.6% | -$2.33M |
|
1207
First Interstate BancSystem
FIBK
$3.58B
| $309M | 0.01% |
8,106,722
-603,856
| -7% | -$21.5M |
|
1208
10x Genomics
TXG
$6.61B
| $309M | 0.01% |
6,822,248
-2,334,744
| -25% | -$121M |
|
1209
Flowserve
FLS
$10.2B
| $309M | 0.01% |
10,780,226
-13,272
| -0.1% | -$423K |
|
1210
Kirby Corp
KEX
$6.93B
| $308M | 0.01% |
5,061,753
+40,710
| +0.8% | +$2.65M |
|
|
APLS
1211
DELISTED
Apellis Pharmaceuticals
APLS
| $307M | 0.01% |
6,798,544
+874,624
| +15% | +$39.9M |
|
1212
Blackbaud
BLKB
$2.08B
| $307M | 0.01% |
5,289,395
-30,630
| -0.6% | -$1.78M |
|
1213
RH
RH
$3.71B
| $307M | 0.01% |
1,444,169
-10,099
| -0.7% | -$3M |
|
1214
IPG Photonics
IPGP
$3.84B
| $306M | 0.01% |
3,253,438
+693,501
| +27% | +$68.5M |
|
|
TPH
1215
DELISTED
Tri Pointe Homes
TPH
| $305M | 0.01% |
18,086,064
+3,859,117
| +27% | +$75.7M |
|
1216
Intellia Therapeutics
NTLA
$1.67B
| $305M | 0.01% |
5,887,399
+285,660
| +5% | +$14.5M |
|
1217
Antero Midstream
AM
$10.1B
| $305M | 0.01% |
33,669,077
+751,919
| +2% | +$7.82M |
|
1218
Axos Financial
AX
$5.68B
| $304M | 0.01% |
8,490,238
-237,371
| -3% | -$9.12M |
|
1219
Dycom Industries
DY
$12.3B
| $304M | 0.01% |
3,265,776
+47,955
| +1% | +$4.27M |
|
1220
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.66B
| $303M | 0.01% |
249,538
-16,344
| -6% | -$20.1M |
|
|
SGI
1221
Somnigroup International
SGI
$13.7B
| $303M | 0.01% |
14,176,338
-1,415,228
| -9% | -$36.5M |
|
1222
Yelp
YELP
$1.41B
| $303M | 0.01% |
10,900,608
+2,990,671
| +38% | +$92.9M |
|
1223
Ingevity
NGVT
$2.68B
| $302M | 0.01% |
4,787,972
+130,606
| +3% | +$8.51M |
|
|
JBGS
1224
JBG SMITH
JBGS
$708M
| $301M | 0.01% |
12,718,879
-401,263
| -3% | -$10.4M |
|
|
GMS
1225
DELISTED
GMS Inc
GMS
| $300M | 0.01% |
6,745,779
-261,733
| -4% | -$12.4M |
|
Similar funds
BlackRock's Q2 2022 Portfolio in Review
As of Q2 2022, BlackRock held 6,138 positions worth $3.12T, down 16% from $3.71T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q2 2022 filing shows 278 new, 2,738 increased, 2,354 reduced and 221 closed positions. Its largest new stake was Aspen Technology Inc: 2,824,931 shares worth $519M. The largest sale was AT&T, an estimated $3.75B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2022 buy was Aspen Technology Inc: 2,824,931 shares worth $519M.
- BlackRock added most to Warner Bros in Q2 2022, an estimated $2.81B increase.
- BlackRock's biggest Q2 2022 reduction was AT&T, cutting an estimated $3.75B.
- BlackRock fully exited Cerner Corp in Q2 2022, selling an estimated $2.23B.
- BlackRock's ten largest holdings make up 19% of its $3.12T portfolio in Q2 2022.
- BlackRock opened 278 new positions and closed 221 in Q2 2022.
- BlackRock's portfolio value fell 16% quarter-over-quarter to $3.12T.
Based on BlackRock's 13F filing for Q2 2022, filed 12 Aug 2022.